Pangraf 1 mg – Composition, Uses and Medicine Enquiries
Product Overview
Pangraf 1 mg contains Tacrolimus, an immunosuppressant medicine belonging to the calcineurin inhibitor category. It works by reducing the activation of certain immune cells, helping prevent the body’s immune system from attacking a transplanted organ.
Tacrolimus is used as part of transplant treatment to help prevent organ rejection. The treatment plan is individualised according to the type of transplant, the patient’s medical history, other prescribed medicines and the transplant specialist’s assessment.
Tacrolimus has a narrow therapeutic range, meaning that maintaining the appropriate medicine concentration in the blood is important. Regular blood-level testing and consistent administration are therefore important parts of treatment.
The exact formulation of Pangraf 1 mg must be verified against the manufacturer-labelled packaging. Immediate-release and prolonged-release tacrolimus products are not automatically interchangeable. Treatment must be managed by a qualified transplant specialist.
Composition and Strength
The supplied product information identifies the following composition:
| Active Ingredient | Strength |
|---|---|
| Tacrolimus | 1 mg |
Product Name: Pangraf 1 mg
Generic Name: Tacrolimus
Brand Name: Pangraf
Strength: 1 mg
Please verify the exact formulation, dosage form and manufacturer details against the original product packaging before publishing this product page or proceeding with an enquiry.
Therapeutic Category and Indication
Pangraf 1 mg belongs to the immunosuppressant medicine category and is classified as a calcineurin inhibitor.
Its clinical use relates to the prevention of organ-transplant rejection. Tacrolimus suppresses immune-cell activation, reducing the likelihood that the immune system will attack a transplanted organ.
It is used as part of an individualised transplant treatment plan under specialist supervision. The appropriate regimen depends on the type of transplant, patient-specific factors, other medicines and the applicable approved product information.
The indications listed here are a general overview, not a substitute for a prescriber’s assessment. The exact approved uses, restrictions and treatment protocols should be checked against the current local prescribing information.
Administration Information
Pangraf 1 mg should be taken orally according to the instructions provided by the treating transplant specialist and the verified product information.
Patients should take tacrolimus at consistent times and follow the formulation-specific instructions concerning food. The administration requirements must be checked against the actual product presentation and its approved label.
Regular blood-level testing may be required to help the transplant team assess whether the prescribed treatment is maintaining the appropriate medicine concentration.
Patients should never switch tacrolimus brands or formulations, adjust the prescribed dose or interrupt treatment without consulting their transplant team. The prescribed schedule, duration and missed-dose instructions must be provided by the treating clinician.
Product Presentation and Availability
The product enquiry can be made using the following details:
- Product Name: Pangraf 1 mg
- Generic Name: Tacrolimus
- Brand Name: Pangraf
- Strength: 1 mg
- Therapeutic Category: Immunosuppressant
- Medicine Class: Calcineurin Inhibitor
- Indication: Prevention of organ-transplant rejection.
The exact formulation, dosage form, company name, manufacturer, pack size and actual product presentation must be confirmed against the manufacturer’s labelled packaging.
In particular, confirm whether the product is an immediate-release or prolonged-release presentation. These formulations are not automatically interchangeable.
Available packaging, batch identification, expiry date and remaining shelf life may vary and should be confirmed by an authorised supplier before any transaction.
A product listing does not confirm current stock, price, availability or eligibility for supply to a particular destination.
Prescription and Patient Safety
Pangraf 1 mg is a prescription immunosuppressant medicine and must be used under the supervision of an appropriately qualified transplant specialist.
Tacrolimus has a narrow therapeutic range, so blood-level monitoring is an important part of treatment. Kidney function and other relevant clinical parameters may also require regular assessment.
Tacrolimus can increase susceptibility to infections and may interact with many other medicines. Patients should inform their healthcare professional about their medical history, any new symptoms and all medicines or supplements they are taking.
Consistent administration is important. Patients should not independently change the dose, switch brands or formulations, interrupt treatment or discontinue the medicine without consulting their transplant team.
The exact precautions, monitoring requirements and possible adverse effects should be checked against the current approved product information.
Medicine Enquiry Coordination Through Medinglobal
Medinglobal provides medicine information, product identification and enquiry coordination. Where appropriate, Medinglobal may help patients, caregivers and eligible healthcare organisations communicate with independent, appropriately authorised pharmaceutical suppliers or service providers.
Medinglobal does not manufacture, stock, sell, dispense or prescribe Pangraf through the website. Any regulated pharmaceutical activity, including prescription verification and lawful supply, remains the responsibility of the relevant independent provider and is subject to applicable laws and regulations.
Availability, prescription requirements, lawful supply routes, supporting documents and destination-country restrictions must be confirmed before any transaction. Submitting an enquiry does not guarantee supply or availability.
How to Submit a Pangraf 1 mg Enquiry
To help identify the requested product, include the following details when submitting an enquiry:
- Product or brand name: Pangraf 1 mg.
- Generic name: Tacrolimus.
- Required strength and formulation.
- Required dosage form and quantity.
- Destination country.
- Prescription or supporting documentation, where applicable.
Where possible, specify whether the prescribed product is an immediate-release or prolonged-release formulation. This information is important for accurate product identification.
Medinglobal may review the submitted details for identification and coordination purposes and, where appropriate, refer the enquiry to an authorised independent provider. The provider is responsible for its own verification, regulatory checks and any subsequent supply decision.
Frequently Asked Questions
What is Pangraf 1 mg used for?
Pangraf 1 mg contains Tacrolimus and is associated with the prevention of organ-transplant rejection. Its use must be determined by a qualified transplant specialist.
What is the generic name of Pangraf 1 mg?
The generic name is Tacrolimus.
What is the strength of Pangraf listed on this page?
The supplied product information identifies Tacrolimus 1 mg. The exact formulation and dosage form should be verified against the original product packaging.
What type of medicine is Pangraf 1 mg?
Pangraf belongs to the immunosuppressant medicine category and is classified as a calcineurin inhibitor.
Does Pangraf 1 mg require blood-level monitoring?
Tacrolimus treatment generally requires monitoring of medicine levels in the blood, along with other clinical assessments as directed by the transplant specialist.
Can different tacrolimus formulations be substituted?
No. Immediate-release and prolonged-release tacrolimus products are not automatically interchangeable. Any change in brand or formulation must be managed by the treating specialist.
Does Pangraf 1 mg require medical supervision?
Yes. It is a prescription immunosuppressant medicine that requires transplant specialist supervision and appropriate clinical monitoring.
Can international patients submit a Pangraf enquiry through Medinglobal?
International enquiries may be submitted. Any coordination or subsequent supply depends on confirmation by an authorised independent provider and compliance with applicable regulations in the relevant countries.
Does Medinglobal sell or dispense Pangraf directly?
No. Medinglobal provides product information, identification and enquiry coordination. It does not itself manufacture, sell, dispense or prescribe the medicine through the website.
Reviews
There are no reviews yet.